MindWalk Holdings (HYFT) Revenue (2020 - 2026)
MindWalk Holdings (HYFT) posted quarterly Revenue of $3.0 billion for Q2 2026, down 38.81% year-over-year from $4.9 billion in Q2 2025, and up 100093.2% quarter-over-quarter from $3.0 million in Q1 2026.
Powered by 
Analysis
MindWalk Holdings (HYFT) Revenue (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Revenue for 7 consecutive years, with $3.0 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Revenue fell 38.81% year-over-year to $3.0 billion; the TTM figure through Apr 2026 stood at $6.0 billion (down 10.95% YoY), while the FY2026 annual figure was $11.3 million, up 48.78% from the prior year.
- Revenue rose to $3.0 billion in Q2 2026 per HYFT's latest filing, from $3.0 million in the prior quarter.
- Across five years, Revenue topped out at $4.9 billion in Q2 2025 and bottomed at -$5.7 million in Q2 2024.
- Historically, Revenue has averaged $707.1 million across 5 years, with a median of $4.0 million in 2022.
- Annual changes were most pronounced in 2022 — Revenue soared 106803022.75% — and 2024, when it slumped 238.12%.
- MindWalk Holdings' Revenue stood at $3.9 million in 2022, then rose by 16.21% to $4.5 million in 2023, then sank by 56.75% to $2.0 million in 2024, then soared by 151439.55% to $3.0 billion in 2025, then rose by 0.98% to $3.0 billion in 2026.
- Business Quant data shows HYFT's Revenue at $3.0 billion in Q2 2026, $3.0 million in Q1 2026, and $3.0 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | 1.71 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | 674.14 Mn |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 425.49 Mn |
| 10 | MindWalk Holdings | 60.76 Mn | 52.48 Mn | 1.82 Mn | 3.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 3.00 Mn |
| Jan 31, 2026 | 3.00 Mn |
| Oct 31, 2025 | 2.97 Mn |
| Jul 31, 2025 | 2.30 Mn |
| Apr 30, 2025 | 4.91 Mn |
| Jan 31, 2025 | 1.92 Mn |
| Oct 31, 2024 | 1.96 Mn |
| Jul 31, 2024 | 1.81 Bn |
| Apr 30, 2024 | -5.74 Mn |
| Jan 31, 2024 | 4.60 Mn |
| Oct 31, 2023 | 4.54 Mn |
| Jul 31, 2023 | 4.26 Mn |
| Apr 30, 2023 | 4.15 Mn |
| Jan 31, 2023 | 3.83 Mn |
| Oct 31, 2022 | 3.90 Mn |
| Jul 31, 2022 | 3.65 Mn |
| Apr 30, 2022 | 4.14 Mn |
| Jan 31, 2022 | 3.80 Mn |
| Oct 31, 2021 | 3.78 Mn |
| Jul 31, 2021 | 3.73 Mn |